AHRENS BRENTON KARL sold 28.8% of their position (33.30K shares) of ITERUM THERAPEUTICS PLC on the open market
Open‑market sale worth $76.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/12/2022ACC: 0000899243-22-030853
Director
Since May 2019
-33.30K
Net shares
Net seller
$76.8K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
33.30K disposed
Non-Derivative Transactions3
Ordinary Shares
Indirect
Shares
−3.30K
Price / share
$2.26
Trade value
$7.47K
% of position
2.9%
9/8/2022
115.54K→112.25K
Ordinary Shares
Indirect
Shares
−15K
Price / share
$2.32
Trade value
$34.73K
% of position
13.4%
9/9/2022
112.25K→97.25K
Ordinary Shares
Indirect
Shares
−15K
Price / share
$2.31
Trade value
$34.61K
% of position
15.4%
9/12/2022
97.25K→82.25K
Total
Net shares
−33.30K
Net value
-$76.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Indirect | 9/8/2022 | S · Sale | −3.30K | $2.26 | $7.47K | 2.9% | 115.54K | 112.25K |
| Ordinary Shares Indirect | 9/9/2022 | S · Sale | −15K | $2.32 | $34.73K | 13.4% | 112.25K | 97.25K |
| Ordinary Shares Indirect | 9/12/2022 | S · Sale | −15K | $2.31 | $34.61K | 15.4% | 97.25K | 82.25K |
| Total | −33.30K | -$76.80K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Ordinary Shares
DirectShares owned410.00
Total
410.00 direct410.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 410.00 | Direct |
| Total | 410.00 | 410.00 direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported